Extrait

To establish the degarelix dosing regimen that most effectively achieves and maintains testosterone suppression at castrate levels during one year of treatment.

Critère d'inclusion

• Patients with prostate cancer requiring androgen ablation therapy

Liens

• euctr
• ictrp
• ictrp
• euctr